Saturn V Capital Management Lp Top Holdings and 13F Report (2025) About Saturn V Capital Management LpInvestment ActivitySaturn V Capital Management Lp has $246.76 million in total holdings as of June 30, 2025.Saturn V Capital Management Lp owns shares of 24 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 35.28% of the portfolio was purchased this quarter.About 23.76% of the portfolio was sold this quarter.This quarter, Saturn V Capital Management Lp has purchased 21 new stocks and bought additional shares in 10 stocks.Saturn V Capital Management Lp sold shares of 9 stocks and completely divested from 2 stocks this quarter.Largest Holdings Jazz Pharmaceuticals $21,961,746Disc Medicine $20,978,250Amylyx Pharmaceuticals $20,900,254Vaxcyte $17,692,625Cogent Biosciences $16,496,222 Largest New Holdings this Quarter G50871105 - Jazz Pharmaceuticals $21,961,746 Holding26818M108 - DYNE THERAPEUTICS INC $13,855,684 Holding52635N103 - LENZ THERAPEUTICS INC $10,033,165 Holding64125C109 - Neurocrine Biosciences $7,312,770 Holding76029N106 - Replimune Group $1,197,639 Holding Largest Purchases this Quarter Jazz Pharmaceuticals 206,952 shares (about $21.96M)DYNE THERAPEUTICS INC 1,455,429 shares (about $13.86M)Vaxcyte 311,926 shares (about $10.14M)LENZ THERAPEUTICS INC 342,312 shares (about $10.03M)Neurocrine Biosciences 58,181 shares (about $7.31M) Largest Sales this Quarter Ascendis Pharma A/S 161,073 shares (about $27.80M)Disc Medicine 122,062 shares (about $6.46M)Merus 98,951 shares (about $5.20M)Syndax Pharmaceuticals 540,729 shares (about $5.06M)Silence Therapeutics 697,726 shares (about $4.05M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSaturn V Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorJAZZJazz Pharmaceuticals$21,961,746$21,961,746 ▲New Holding206,9528.9%MedicalIRONDisc Medicine$20,978,250$6,464,403 ▼-23.6%396,1158.5%MedicalAMLXAmylyx Pharmaceuticals$20,900,254$5,346,799 ▲34.4%3,260,5708.5%MedicalPCVXVaxcyte$17,692,625$10,140,714 ▲134.3%544,2217.2%MedicalCOGTCogent Biosciences$16,496,222$5,869,679 ▲55.2%2,297,5246.7%MedicalCELCCelcuity$15,826,692$1,226,104 ▲8.4%1,185,5206.4%MedicalCG ONCOLOGY INC$15,252,822$232,726 ▲1.5%586,6476.2%COMXENEXenon Pharmaceuticals$14,659,793$1,710,639 ▲13.2%468,3645.9%MedicalDYNE THERAPEUTICS INC$13,855,684$13,855,684 ▲New Holding1,455,4295.6%COMMLTXMoonLake Immunotherapeutics$13,725,005$2,504,668 ▼-15.4%290,7845.6%MedicalMRUSMerus$11,796,076$5,204,823 ▼-30.6%224,2604.8%MedicalCNTACentessa Pharmaceuticals$10,424,317$4,528,504 ▲76.8%793,3274.2%MedicalLENZ THERAPEUTICS INC$10,033,165$10,033,165 ▲New Holding342,3124.1%COMNBIXNeurocrine Biosciences$7,312,770$7,312,770 ▲New Holding58,1813.0%MedicalOCULOcular Therapeutix$6,761,185$1,209,973 ▲21.8%728,5762.7%MedicalASNDAscendis Pharma A/S$6,591,767$27,801,201 ▼-80.8%38,1912.7%MedicalARGXargenex$5,669,298$1,971,714 ▼-25.8%10,2852.3%MedicalABIVAX SA$4,761,964$532,080 ▲12.6%622,4791.9%SPONSORED ADSSNDXSyndax Pharmaceuticals$4,687,660$5,063,927 ▼-51.9%500,5511.9%MedicalNAMSNewAmsterdam Pharma$3,996,786$1,889,633 ▲89.7%220,6951.6%MedicalCONTINEUM THERAPEUTICS INC$1,267,812$959,275 ▼-43.1%319,3480.5%CL AREPLReplimune Group$1,197,639$1,197,639 ▲New Holding128,9170.5%MedicalKALVKalVista Pharmaceuticals$709,875$2,173,579 ▼-75.4%62,7930.3%MedicalSLNSilence Therapeutics$201,475$4,046,819 ▼-95.3%34,7370.1%MedicalCRNXCrinetics Pharmaceuticals$0$1,979,430 ▼-100.0%00.0%MedicalINZYInozyme Pharma$0$454,321 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access